​

Merit Medical Systems (MMSI) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

MMSI Stock Forecast

Merit Medical Systems stock forecast is as follows: an average price target of $105.60 (represents a -2.65% downside from MMSI’s last price of $108.48) and a rating consensus of 'Buy', based on 6 wall street analysts offering a 1-year stock forecast.

MMSI Price Target

The average price target for Merit Medical Systems (MMSI) is $105.60 based on 1-year price targets from 6 Wall Street analysts in the past 3 months, with a price target range of $110.00 to $103.00. This represents a potential -2.65% downside from MMSI's last price of $108.48.

MMSI Analyst Ratings

Buy

According to 6 Wall Street analysts, Merit Medical Systems's rating consensus is 'Buy'. The analyst rating breakdown for MMSI stock is 0 'Strong Buy' (0.00%), 5 'Buy' (83.33%), 1 'Hold' (16.67%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Merit Medical Systems Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 15, 2024David RescottRobert W. Baird$107.00$95.5212.02%-1.36%
Sep 16, 2024Mike MatsonNeedham$105.00$96.169.19%-3.21%
Sep 16, 2024Larry BiegelsenWells Fargo$103.00$96.167.11%-5.05%
Sep 16, 2024Craig BijouBank of America Securities$103.00$96.167.11%-5.05%
Sep 09, 2024Jason BednarPiper Sandler$110.00$96.5813.90%1.40%
Aug 05, 2024Craig BijouBank of America Securities$92.00$87.445.22%-15.19%
Aug 02, 2024Jason BednarPiper Sandler$100.00$86.8615.13%-7.82%
Jul 02, 2024John YoungCanaccord Genuity$125.00$85.6445.96%15.23%
Jun 13, 2024Larry BiegelsenWells Fargo$85.00$83.252.10%-21.64%
May 01, 2024Jason BednarPiper Sandler$97.00$77.1225.78%-10.58%
Apr 11, 2024Kristen StewartC.L. King$88.00$71.9522.31%-18.88%
Oct 27, 2023Mike MatsonNeedham$81.00$68.8317.68%-25.33%
Jul 06, 2023Michael PetuskyBarrington$95.00$79.3519.72%-12.43%
Jun 09, 2023Mike MatsonNeedham$96.00$83.8114.54%-11.50%
Apr 27, 2023Mike MatsonNeedham$90.00$81.7610.08%-17.04%
Sep 02, 2022Canaccord Genuity$69.00$57.3920.23%-36.39%
Jul 28, 2022Raymond James$71.00$56.8025.00%-34.55%

The latest Merit Medical Systems stock forecast, released on Oct 15, 2024 by David Rescott from Robert W. Baird, set a price target of $107.00, which represents a 12.02% increase from the stock price at the time of the forecast ($95.52), and a -1.36% decrease from MMSI last price ($108.48).

Merit Medical Systems Price Target by Period

1M3M12M
# Anlaysts--11
Avg Price Target--$101.36
Last Closing Price$108.48$108.48$108.48
Upside/Downside-100.00%-100.00%-6.56%

In the current month, the average price target of Merit Medical Systems stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Merit Medical Systems's last price of $108.48. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Dec 11, 2024Wells FargoBuyOverweightUpgrade
Oct 18, 2024Sandler O'NeillUnderperformUnderperformHold
Oct 18, 2024Wells FargoBuyBuyHold
Sep 17, 2024Canaccord GenuityBuyBuyHold
Sep 16, 2024Wells FargoBuyBuyHold
Sep 16, 2024Sandler O'NeillUnderperformUnderperformHold
Sep 16, 2024NeedhamBuyBuyHold
Sep 16, 2024Wells FargoEqual-WeightEqual-WeightHold
Sep 16, 2024Bank of America SecuritiesNeutralNeutralHold
Sep 09, 2024Piper SandlerOverweightOverweightHold
Aug 28, 2024NeedhamUnderperformUnderperformHold
Aug 28, 2024Piper SandlerBuyBuyHold
Aug 05, 2024Bank of America SecuritiesNeutralNeutralHold
Aug 02, 2024Piper SandlerOverweightOverweightHold
Aug 02, 2024NeedhamBuyBuyHold
Aug 02, 2024Canaccord GenuityUnderperformUnderperformHold
Jul 02, 2024Canaccord GenuityBuyBuyHold
Jun 28, 2024Piper SandlerBuyBuyHold
Jun 28, 2024NeedhamUnderperformUnderperformHold
Jun 18, 2024Piper SandlerOverweightOverweightHold
Jun 13, 2024Wells FargoEqual-WeightEqual-WeightHold
May 01, 2024Piper SandlerBuyBuyHold
May 01, 2024Piper SandlerOverweightOverweightHold
Apr 11, 2024OppenheimerUnderperformUnderperformHold
Apr 11, 2024Raymond JamesBuyBuyHold
Dec 21, 2023Canaccord GenuityUnderperformUnderperformHold
Dec 21, 2023NeedhamBuyBuyHold
Oct 27, 2023NeedhamBuyBuyHold
Jul 26, 2023NeedhamBuyBuyHold
Jun 09, 2023NeedhamBuyBuyHold
Apr 27, 2023NeedhamBuyBuyHold
Sep 02, 2022Canaccord GenuityBuyBuyHold
Jul 28, 2022Raymond JamesOutperformOutperformHold
Jul 01, 2022Piper SandlerOverweightOverweightHold
Feb 25, 2022Raymond JamesOutperformOutperformHold
Feb 25, 2022NeedhamBuyBuyHold

Merit Medical Systems's last stock rating was published by Wells Fargo on Dec 11, 2024. The company Upgrade its MMSI rating from "Buy" to "Overweight".

Merit Medical Systems Financial Forecast

Merit Medical Systems Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Revenue--------------$320.06M$297.56M$293.42M$287.18M$294.98M$275.42M$278.49M$267.02M$280.32M$248.91M$258.00M$243.97M$218.37M$243.53M$257.92M$243.05M
Avg Forecast$398.98M$391.37M$393.09M$375.25M$377.51M$368.86M$372.66M$352.88M$349.16M$334.60M$334.56M$315.57M$320.66M$306.19M$310.10M$280.50M$290.14M$272.52M$280.55M$264.38M$270.91M$260.61M$250.60M$230.88M$250.47M$217.63M$192.67M$231.57M$252.31M$248.55M
High Forecast$406.37M$398.62M$400.38M$382.21M$384.51M$375.70M$379.57M$359.41M$356.32M$334.66M$334.56M$315.57M$326.92M$306.19M$315.85M$285.70M$294.13M$272.52M$280.55M$264.38M$270.91M$260.61M$250.60M$230.88M$250.47M$217.63M$192.67M$231.57M$252.31M$248.55M
Low Forecast$392.81M$385.32M$387.02M$369.46M$371.68M$363.16M$366.90M$349.18M$346.15M$334.55M$334.56M$315.57M$315.80M$306.19M$305.31M$276.16M$286.50M$272.52M$280.55M$264.38M$270.91M$260.61M$250.60M$230.88M$250.47M$217.63M$192.67M$231.57M$252.31M$248.55M
# Analysts333344467333633344443333633322
Surprise %--------------1.03%1.06%1.01%1.05%1.05%1.04%1.03%1.02%1.12%1.08%1.03%1.12%1.13%1.05%1.02%0.98%

Merit Medical Systems's average Quarter revenue forecast for Sep 23 based on 3 analysts is $306.19M, with a low forecast of $306.19M, and a high forecast of $306.19M. MMSI's average Quarter revenue forecast represents a -4.33% decrease compared to the company's last Quarter revenue of $320.06M (Jun 23).

Merit Medical Systems EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts333344467333633344443333633322
EBITDA--------------$56.55M$51.23M$55.84M$43.46M$52.88M$42.49M$44.96M$39.03M$32.27M$38.70M$42.02M$26.61M$7.34M$27.61M$22.07M$24.57M
Avg Forecast$56.85M$55.76M$56.01M$53.47M$53.79M$52.56M$53.10M$50.28M$49.75M$47.68M$47.67M$40.35M$45.69M$43.63M$44.18M$36.68M$31.38M$32.29M$33.24M$33.34M$32.10M$30.88M$29.69M$23.65M$29.68M$25.79M$22.83M$16.35M$29.90M$29.45M
High Forecast$57.90M$56.80M$57.05M$54.46M$54.79M$53.53M$54.08M$51.21M$50.77M$47.68M$47.67M$48.41M$46.58M$43.63M$45.00M$44.01M$37.66M$32.29M$33.24M$40.01M$32.10M$30.88M$29.69M$28.38M$29.68M$25.79M$22.83M$19.62M$29.90M$29.45M
Low Forecast$55.97M$54.90M$55.14M$52.64M$52.96M$51.75M$52.28M$49.75M$49.32M$47.67M$47.67M$32.28M$45.00M$43.63M$43.50M$29.34M$25.11M$32.29M$33.24M$26.67M$32.10M$30.88M$29.69M$18.92M$29.68M$25.79M$22.83M$13.08M$29.90M$29.45M
Surprise %--------------1.28%1.40%1.78%1.35%1.59%1.27%1.40%1.26%1.09%1.64%1.42%1.03%0.32%1.69%0.74%0.83%

3 analysts predict MMSI's average Quarter EBITDA for Sep 23 to be $43.63M, with a high of $43.63M and a low of $43.63M. This is -22.85% lower than Merit Medical Systems's previous annual EBITDA (Jun 23) of $56.55M.

Merit Medical Systems Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts333344467333633344443333633322
Net Income--------------$20.25M$20.70M$33.40M$15.27M$15.30M$10.54M$20.61M$11.97M$4.92M$10.96M$15.38M$-3.01M$-19.06M$-3.15M$-4.21M$-3.40M
Avg Forecast$67.47M$62.20M$63.09M$54.64M$57.85M$56.21M$57.89M$49.39M$49.10M$47.51M$52.04M$11.13M$45.62M$38.53M$44.78M$10.12M$14.39M$31.05M$33.90M$9.20M$29.71M$25.63M$26.29M$6.70M$25.48M$11.60M$3.82M$-1.87M$20.12M$26.21M
High Forecast$69.10M$63.70M$64.61M$55.96M$59.24M$57.57M$59.28M$52.37M$50.28M$47.54M$53.29M$13.36M$46.81M$38.53M$45.86M$12.14M$17.27M$31.05M$33.90M$11.04M$29.71M$25.63M$26.29M$8.04M$25.48M$11.60M$3.82M$-1.49M$20.12M$26.21M
Low Forecast$66.12M$60.96M$61.82M$53.54M$56.68M$55.08M$56.73M$47.01M$47.92M$47.48M$50.99M$8.90M$44.44M$38.52M$43.88M$8.09M$11.51M$31.05M$33.90M$7.36M$29.71M$25.63M$26.29M$5.36M$25.48M$11.60M$3.82M$-2.24M$20.12M$26.21M
Surprise %--------------0.45%2.05%2.32%0.49%0.45%1.15%0.69%0.47%0.19%1.64%0.60%-0.26%-4.99%1.69%-0.21%-0.13%

Merit Medical Systems's average Quarter net income forecast for Sep 23 is $38.53M, with a range of $38.52M to $38.53M. MMSI's average Quarter net income forecast represents a 90.31% increase compared to the company's last Quarter net income of $20.25M (Jun 23).

Merit Medical Systems SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts333344467333633344443333633322
SG&A--------------$100.93M$90.14M$83.24M$89.78M$85.49M$84.02M$76.63M$86.47M$91.56M$81.02M$79.93M$72.22M$66.77M$78.81M$82.09M$86.94M
Avg Forecast$123.28M$120.93M$121.46M$115.95M$116.65M$113.98M$115.15M$109.04M$107.89M$103.39M$103.38M$88.68M$99.08M$94.61M$95.82M$80.62M$53.49M$81.82M$84.23M$73.29M$81.34M$78.25M$75.24M$49.51M$75.20M$65.34M$57.85M$46.68M$75.75M$74.63M
High Forecast$125.57M$123.17M$123.72M$118.10M$118.81M$116.09M$117.28M$111.05M$110.10M$103.41M$103.38M$106.42M$101.02M$94.61M$97.60M$96.74M$64.19M$81.82M$84.23M$87.95M$81.34M$78.25M$75.24M$59.42M$75.20M$65.34M$57.85M$56.01M$75.75M$74.63M
Low Forecast$121.38M$119.06M$119.59M$114.16M$114.85M$112.22M$113.37M$107.89M$106.96M$103.37M$103.38M$70.94M$97.58M$94.61M$94.34M$64.49M$42.79M$81.82M$84.23M$58.63M$81.34M$78.25M$75.24M$39.61M$75.20M$65.34M$57.85M$37.34M$75.75M$74.63M
Surprise %--------------1.05%1.12%1.56%1.10%1.01%1.15%0.94%1.11%1.22%1.64%1.06%1.11%1.15%1.69%1.08%1.16%

Merit Medical Systems's average Quarter SG&A projection for Sep 23 is $94.61M, based on 3 Wall Street analysts, with a range of $94.61M to $94.61M. The forecast indicates a -6.26% fall compared to MMSI last annual SG&A of $100.93M (Jun 23).

Merit Medical Systems EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts333344467333633344443333633322
EPS--------------$0.35$0.36$0.58$0.27$0.27$0.19$0.36$0.21$0.09$0.20$0.28$-0.05$-0.34$-0.06$-0.08$-0.06
Avg Forecast$1.13$1.04$1.06$0.92$0.97$0.94$0.97$0.83$0.82$0.80$0.87$0.71$0.77$0.65$0.75$0.55$0.67$0.53$0.58$0.47$0.51$0.44$0.45$0.36$0.43$0.20$0.07$0.26$0.34$0.45
High Forecast$1.16$1.07$1.09$0.94$1.00$0.97$1.00$0.88$0.84$0.80$0.90$0.71$0.79$0.65$0.77$0.56$0.68$0.53$0.58$0.47$0.51$0.44$0.45$0.36$0.43$0.20$0.07$0.26$0.34$0.45
Low Forecast$1.11$1.02$1.04$0.90$0.95$0.93$0.95$0.79$0.80$0.80$0.86$0.71$0.75$0.65$0.74$0.53$0.66$0.53$0.58$0.47$0.51$0.44$0.45$0.36$0.43$0.20$0.07$0.26$0.34$0.45
Surprise %--------------0.47%0.66%0.86%0.51%0.47%0.41%0.71%0.48%0.20%0.56%0.65%-0.25%-5.23%-0.23%-0.23%-0.13%

According to 3 Wall Street analysts, Merit Medical Systems's projected average Quarter EPS for Sep 23 is $0.65, with a low estimate of $0.65 and a high estimate of $0.65. This represents a 84.90% increase compared to MMSI previous annual EPS of $0.35 (Jun 23).

Merit Medical Systems Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
COOCooper Companies$98.00$250.86155.98%Buy
HAEHaemonetics$68.29$107.0056.68%Buy
TFXTeleflex$180.58$257.6742.69%Buy
ATRAptarGroup$157.11$200.0027.30%Buy
ALCAlcon$91.38$107.8017.97%Buy
WSTWest Pharmaceutical Services$339.57$393.0015.73%Buy
ICUIICU Medical$168.30$190.5013.19%Buy
ANGOAngioDynamics$12.46$13.004.33%Buy
XRAYDENTSPLY SIRONA$19.63$20.001.88%Hold
MMSIMerit Medical Systems$108.48$105.60-2.65%Buy
NVSTEnvista$21.37$20.29-5.05%Hold
RMDResMed$252.86$233.50-7.66%Hold

MMSI Forecast FAQ

Is Merit Medical Systems a good buy?

Yes, according to 6 Wall Street analysts, Merit Medical Systems (MMSI) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 5 'Buy' recommendations, accounting for 83.33% of MMSI's total ratings.

What is MMSI's price target?

Merit Medical Systems (MMSI) average price target is $105.6 with a range of $103 to $110, implying a -2.65% from its last price of $108.48. The data is based on 6 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Merit Medical Systems stock go up soon?

According to Wall Street analysts' prediction for MMSI stock, the company can go down by -2.65% (from the last price of $108.48 to the average price target of $105.6), up by 1.40% based on the highest stock price target, and down by -5.05% based on the lowest stock price target.

Can Merit Medical Systems stock reach $200?

MMSI's average twelve months analyst stock price target of $105.6 does not support the claim that Merit Medical Systems can reach $200 in the near future.

What are Merit Medical Systems's analysts' financial forecasts?

Merit Medical Systems's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $1.47B (high $1.5B, low $1.45B), average EBITDA is $209.72M (high $213.61M, low $206.73M), average net income is $221.34M (high $228.46M, low $215.5M), average SG&A $454.81M (high $463.24M, low $448.33M), and average EPS is $3.72 (high $3.84, low $3.62). MMSI's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $1.56B (high $1.59B, low $1.53B), average EBITDA is $222.09M (high $226.21M, low $218.66M), average net income is $247.4M (high $253.37M, low $242.44M), average SG&A $481.63M (high $490.56M, low $474.19M), and average EPS is $4.16 (high $4.26, low $4.07).

Did the MMSI's actual financial results beat the analysts' financial forecasts?

Based on Merit Medical Systems's last annual report (Dec 2022), the company's revenue was $1.15B, beating the average analysts forecast of $1.11B by 3.92%. Apple's EBITDA was $194.67M, beating the average prediction of $130.26M by 49.45%. The company's net income was $74.52M, missing the average estimation of $88.54M by -15.84%. Apple's SG&A was $342.52M, beating the average forecast of $292.83M by 16.97%. Lastly, the company's EPS was $1.31, missing the average prediction of $2.24 by -41.59%. In terms of the last quarterly report (Jun 2023), Merit Medical Systems's revenue was $320.06M, beating the average analysts' forecast of $310.1M by 3.21%. The company's EBITDA was $56.55M, beating the average prediction of $44.18M by 27.98%. Merit Medical Systems's net income was $20.24M, missing the average estimation of $44.78M by -54.79%. The company's SG&A was $100.93M, beating the average forecast of $95.82M by 5.33%. Lastly, the company's EPS was $0.35, missing the average prediction of $0.752 by -53.46%